96 related articles for article (PubMed ID: 20178453)
21. Characterization of the NADPH-dependent metabolism of 17beta-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5.
Lee AJ; Kosh JW; Conney AH; Zhu BT
J Pharmacol Exp Ther; 2001 Aug; 298(2):420-32. PubMed ID: 11454902
[TBL] [Abstract][Full Text] [Related]
22. Determination of species-difference in microsomal metabolism of amitriptyline using a predictive MRM-IDA-EPI method.
Lee JY; Lee SY; Lee K; Oh SJ; Kim SK
Chem Biol Interact; 2015 Mar; 229():109-18. PubMed ID: 25623954
[TBL] [Abstract][Full Text] [Related]
23. Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources.
Rotzinger S; Fang J; Baker GB
Drug Metab Dispos; 1998 Jun; 26(6):572-5. PubMed ID: 9616194
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the metabolism of sibiricaxanthone F and its aglycone in vitro by high performance liquid chromatography coupled with Q-trap mass spectrometry.
Song Y; Yang X; Jiang Y; Tu P
J Pharm Biomed Anal; 2012 Nov; 70():700-7. PubMed ID: 22819207
[TBL] [Abstract][Full Text] [Related]
25. Study of in-vitro metabolism of selected antibiotic drugs in human liver microsomes by liquid chromatography coupled with tandem mass spectrometry.
Szultka-Mlynska M; Buszewski B
Anal Bioanal Chem; 2016 Nov; 408(29):8273-8287. PubMed ID: 27704178
[TBL] [Abstract][Full Text] [Related]
26. High-field asymmetric waveform ion mobility spectrometry coupled with liquid chromatography/electrospray ionization tandem mass spectrometry (LC/ESI-FAIMS-MS/MS) multi-component bioanalytical method development, performance evaluation and demonstration of the constancy of the compensation voltage with change of mobile phase composition or flow rate.
Wu ST; Xia YQ; Jemal M
Rapid Commun Mass Spectrom; 2007; 21(22):3667-76. PubMed ID: 17939154
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations.
Egorin MJ; Rosen DM; Wolff JH; Callery PS; Musser SM; Eiseman JL
Cancer Res; 1998 Jun; 58(11):2385-96. PubMed ID: 9622079
[TBL] [Abstract][Full Text] [Related]
28. Identification of human liver cytochrome P450 enzymes involved in biotransformation of vicriviroc, a CCR5 receptor antagonist.
Ghosal A; Ramanathan R; Yuan Y; Hapangama N; Chowdhury SK; Kishnani NS; Alton KB
Drug Metab Dispos; 2007 Dec; 35(12):2186-95. PubMed ID: 17827338
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
Wu WN; McKown LA; Reitz AB
Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
[TBL] [Abstract][Full Text] [Related]
30. Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.
Murayama N; Imai N; Nakane T; Shimizu M; Yamazaki H
Biochem Pharmacol; 2007 Jun; 73(12):2020-6. PubMed ID: 17433262
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel glutathione conjugate of flutamide in incubations with human liver microsomes.
Kang P; Dalvie D; Smith E; Zhou S; Deese A
Drug Metab Dispos; 2007 Jul; 35(7):1081-8. PubMed ID: 17403914
[TBL] [Abstract][Full Text] [Related]
32. In vitro metabolism of BIIB021, an inhibitor of heat shock protein 90, in liver microsomes and hepatocytes of rats, dogs, and humans and recombinant human cytochrome P450 isoforms.
Xu L; Woodward C; Khan S; Prakash C
Drug Metab Dispos; 2012 Apr; 40(4):680-93. PubMed ID: 22217465
[TBL] [Abstract][Full Text] [Related]
33. Determination of nefazodone and its pharmacologically active metabolites in human blood plasma and breast milk by high-performance liquid chromatography.
Dodd S; Buist A; Burrows GD; Maguire KP; Norman TR
J Chromatogr B Biomed Sci Appl; 1999 Jul; 730(2):249-55. PubMed ID: 10448960
[TBL] [Abstract][Full Text] [Related]
34. Carbamazepine-nefazodone interaction in healthy subjects.
Laroudie C; Salazar DE; Cosson JP; Cheuvart B; Istin B; Girault J; Ingrand I; Decourt JP
J Clin Psychopharmacol; 2000 Feb; 20(1):46-53. PubMed ID: 10653208
[TBL] [Abstract][Full Text] [Related]
35. Influence of hepatic impairment on the pharmacokinetics of nefazodone and two of its metabolites after single and multiple oral doses.
Ferry N; Bernard N; Cuisinaud G; Rougier P; Trepo C; Sassard J
Fundam Clin Pharmacol; 1994; 8(5):463-73. PubMed ID: 7875642
[TBL] [Abstract][Full Text] [Related]
36. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
Hesse LM; Venkatakrishnan K; Court MH; von Moltke LL; Duan SX; Shader RI; Greenblatt DJ
Drug Metab Dispos; 2000 Oct; 28(10):1176-83. PubMed ID: 10997936
[TBL] [Abstract][Full Text] [Related]
37. In vitro characterization of 4'-(p-toluenesulfonylamide)-4-hydroxychalcone using human liver microsomes and recombinant cytochrome P450s.
Lee B; Wu Z; Lee T; Tan XF; Park KH; Liu KH
Xenobiotica; 2016; 46(4):350-6. PubMed ID: 26330107
[TBL] [Abstract][Full Text] [Related]
38. Determination of nefazodone and its metabolites in plasma by high-performance liquid chromatography with coulometric detection.
Franklin M
J Pharm Biomed Anal; 1993; 11(11-12):1109-13. PubMed ID: 8123721
[TBL] [Abstract][Full Text] [Related]
39. Metabolic screening using on-line ultrafiltration mass spectrometry.
van Breemen RB; Nikolic D; Bolton JL
Drug Metab Dispos; 1998 Feb; 26(2):85-90. PubMed ID: 9456292
[TBL] [Abstract][Full Text] [Related]
40. Bioactivation of the tricyclic antidepressant amitriptyline and its metabolite nortriptyline to arene oxide intermediates in human liver microsomes and recombinant P450s.
Wen B; Ma L; Zhu M
Chem Biol Interact; 2008 May; 173(1):59-67. PubMed ID: 18359012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
